This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

About the Drug Discovery, Development & Evaluation Affinity Group

The Drug Discovery, Development & Evaluation Affinity Group serves members with interests in all aspects from drug discovery to prescribed use including target identification, drug development, safety pharmacology, conduct of medical research and clinical trials, approval and licensing. This includes all areas of the drug discovery and development process including ‘omics approaches, drug-screening, molecular, cellular, systems or whole organism approaches, pharmacokinetics, pharmacodynamics, pharmacoepidemiology, pharmacoeconomics, clinical testing, drug regulation and registration, adverse drug reactions along with all aspects relevant to the post-market distribution and utilisation of drugs. Drug discovery also serves members with interests in natural products and nutraceuticals.

Sign up to the Drug Discovery, Development & Evaluation Affinity Group through the 'Committees & Groups' tab on the 'Update my profile' page.
 

Contact the Co-Chairs

Email the Co-Chairs at: affinitygroups@bps.ac.uk‚Äč
 

Co-chairs


Liz Rosethorne  







Dave Kendall